+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Pathway Information System Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 216 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994272
The clinical pathway information system market was valued at $0.8 billion in 2023 and is projected to reach $1.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

A clinical pathway information system is specialized software designed for healthcare settings to manage and optimize their operations. This system reduces variations in clinical practice and promotes the standardization of multidisciplinary activities. The clinical pathway information system further facilitates the adoption of evidence-based practice in the clinical settings. The major advantage of using such systems includes improved healthcare delivery, swift coordination, data-driven insights, and enhanced efficiency in patient care. The information system efficiently integrates with the electronic healthcare system, enabling quick access to patient data and rapid documentation procedures in the healthcare facilities.

To promote consistency in patient care and ensure standardization of clinical practices in healthcare settings across the globe, there is a significant demand for clinical pathway information systems. In addition, technological advancements facilitate the assimilation of information systems with other healthcare systems, thereby improving the clinical outcomes. This acts as a major driver of the clinical pathway information system market. Moreover, the adoption of information systems is witnessing a surge as they help the healthcare facilities to avoid unnecessary operational costs through improved resource utilization. In the coming future, the convergence of clinical pathway information system and telemedicine is anticipated to be a prominent trend. This convergence is projected to facilitate the transfer of patient data among different healthcare facilities and foster the development of suitable applications that promote remote patient care.

However, the implementation of clinical pathway information system is a highly cost-intensive and intricate process with expenses associated with maintenance & updates and challenges pertaining to assimilation with the existing infrastructure. These factors hamper the growth of the market significantly. Furthermore, complete dependence on technology holds the potential to disrupt the entire workflow at times of system outages and technical issues, deterring several medical facilities from adopting the advanced information systems. On the contrary, upsurge in the utility of electronic health records (EHR) systems among several physicians and doctors is expected to open new avenues for market expansion. According to the statistics published by Statista, a global data and business intelligence platform, approximately 88% of the total doctors were using EHR systems in the U.S. The platform further predicts the figure to rise in the future.

Segment Review

The clinical pathway information system market is segmented into type, mode of delivery, end user, and region. On the basis of type, the market is divided into group order type, embodied variant type, and reconstructed information type. As per mode of delivery, it is classified into on-premises, cloud-based, and web-based. Depending on end user, it is categorized into hospitals, ambulatory care centers, specialty clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competition Analysis

The key players operating in the global clinical pathway information system market include McKesson Corporation, Civica, GE Healthcare, Koninklijke Philips N.V., EPIC Systems Corporation, Optum, Inc., PointClickCare, Cerner Corporation, Philips Healthcare, and Athenahealth. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Reimbursement Scenario

Key Market Segments

By Type

  • Group Order Type
  • Embodied Variant Type
  • Reconstructed Information Type

By Mode Of Delivery

  • On-Premises
  • Cloud-Based
  • Web-Based

By End User

  • Hospitals
  • Ambulatory Care Centers
  • Specialty Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
Key Market Players
  • McKesson Corporation
  • Civica
  • GE Healthcare
  • Koninklijke Philips N.V.
  • EPIC Systems Corporation
  • Optum, Inc.
  • PointClickCare
  • Cerner Corporation
  • Philips Healthcare
  • Athenahealth

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Group Order Type
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Embodied Variant Type
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Reconstructed Information Type
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Mode of Delivery
5.2. On-Premises
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Cloud-Based
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Web-Based
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Care Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Specialty Clinics
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Mode of Delivery
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Clinical Pathway Information System Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Mode of Delivery
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Clinical Pathway Information System Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Mode of Delivery
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Clinical Pathway Information System Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Mode of Delivery
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Mode of Delivery
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Clinical Pathway Information System Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Mode of Delivery
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Clinical Pathway Information System Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Mode of Delivery
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Clinical Pathway Information System Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Mode of Delivery
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Clinical Pathway Information System Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Mode of Delivery
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Clinical Pathway Information System Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Mode of Delivery
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Clinical Pathway Information System Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Mode of Delivery
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Mode of Delivery
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Clinical Pathway Information System Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Mode of Delivery
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Clinical Pathway Information System Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Mode of Delivery
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Clinical Pathway Information System Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Mode of Delivery
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Clinical Pathway Information System Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Mode of Delivery
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Clinical Pathway Information System Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Mode of Delivery
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Clinical Pathway Information System Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Mode of Delivery
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Mode of Delivery
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Clinical Pathway Information System Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Mode of Delivery
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Clinical Pathway Information System Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Mode of Delivery
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Clinical Pathway Information System Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Mode of Delivery
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Clinical Pathway Information System Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Mode of Delivery
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. McKesson Corporation
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Civica
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. GE Healthcare
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Koninklijke Philips N.V.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. EPIC Systems Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Optum, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. PointClickCare
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Cerner Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Philips Healthcare
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Athenahealth
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 2. Clinical Pathway Information System Market for Group Order Type, by Region, 2024 - 2033 ($Billion)
Table 3. Clinical Pathway Information System Market for Embodied Variant Type, by Region, 2024 - 2033 ($Billion)
Table 4. Clinical Pathway Information System Market for Reconstructed Information Type, by Region, 2024 - 2033 ($Billion)
Table 5. Global Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 6. Clinical Pathway Information System Market for On-Premises, by Region, 2024 - 2033 ($Billion)
Table 7. Clinical Pathway Information System Market for Cloud-based, by Region, 2024 - 2033 ($Billion)
Table 8. Clinical Pathway Information System Market for Web-based, by Region, 2024 - 2033 ($Billion)
Table 9. Global Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 10. Clinical Pathway Information System Market for Hospitals, by Region, 2024 - 2033 ($Billion)
Table 11. Clinical Pathway Information System Market for Ambulatory Care Centers, by Region, 2024 - 2033 ($Billion)
Table 12. Clinical Pathway Information System Market for Specialty Clinics, by Region, 2024 - 2033 ($Billion)
Table 13. Clinical Pathway Information System Market for Others, by Region, 2024 - 2033 ($Billion)
Table 14. Clinical Pathway Information System Market, by Region, 2024 - 2033 ($Billion)
Table 15. North America Clinical Pathway Information System Market, by Country, 2024 - 2033 ($Billion)
Table 16. North America Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 17. North America Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 18. North America Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 19. U.S. Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 20. U.S. Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 21. U.S. Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 22. Canada Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 23. Canada Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 24. Canada Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Mexico Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 26. Mexico Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 27. Mexico Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 28. Europe Clinical Pathway Information System Market, by Country, 2024 - 2033 ($Billion)
Table 29. Europe Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 30. Europe Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 31. Europe Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 32. France Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 33. France Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 34. France Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 35. Germany Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 36. Germany Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 37. Germany Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 38. Italy Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 39. Italy Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 40. Italy Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 41. Spain Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 42. Spain Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 43. Spain Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 44. UK Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 45. UK Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 46. UK Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 47. Rest of Europe Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 48. Rest of Europe Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 49. Rest of Europe Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 50. Asia-Pacific Clinical Pathway Information System Market, by Country, 2024 - 2033 ($Billion)
Table 51. Asia-Pacific Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 52. Asia-Pacific Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 53. Asia-Pacific Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 54. China Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 55. China Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 56. China Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 57. Japan Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 58. Japan Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 59. Japan Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 60. India Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 61. India Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 62. India Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 63. South Korea Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 64. South Korea Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 65. South Korea Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 66. Australia Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 67. Australia Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 68. Australia Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 69. Rest of Asia-Pacific Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 70. Rest of Asia-Pacific Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 71. Rest of Asia-Pacific Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 72. LAMEA Clinical Pathway Information System Market, by Country, 2024 - 2033 ($Billion)
Table 73. LAMEA Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 74. LAMEA Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 75. LAMEA Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 76. Brazil Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 77. Brazil Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 78. Brazil Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 79. South Africa Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 80. South Africa Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 81. South Africa Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 82. Saudi Arabia Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 83. Saudi Arabia Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 84. Saudi Arabia Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 85. Rest of LAMEA Clinical Pathway Information System Market, by Type, 2024 - 2033 ($Billion)
Table 86. Rest of LAMEA Clinical Pathway Information System Market, by Mode of Delivery, 2024 - 2033 ($Billion)
Table 87. Rest of LAMEA Clinical Pathway Information System Market, by End-user, 2024 - 2033 ($Billion)
Table 88. Mckesson Corporation: Key Executives
Table 89. Mckesson Corporation: Company Snapshot
Table 90. Mckesson Corporation: Operating Segments
Table 91. Mckesson Corporation: Product Portfolio
Table 92. Mckesson Corporation: Key Strategic Moves and Developments
Table 93. Civica: Key Executives
Table 94. Civica: Company Snapshot
Table 95. Civica: Operating Segments
Table 96. Civica: Product Portfolio
Table 97. Civica: Key Strategic Moves and Developments
Table 98. GE Healthcare: Key Executives
Table 99. GE Healthcare: Company Snapshot
Table 100. GE Healthcare: Operating Segments
Table 101. GE Healthcare: Product Portfolio
Table 102. GE Healthcare: Key Strategic Moves and Developments
Table 103. Koninklijke Philips N.V.: Key Executives
Table 104. Koninklijke Philips N.V.: Company Snapshot
Table 105. Koninklijke Philips N.V.: Operating Segments
Table 106. Koninklijke Philips N.V.: Product Portfolio
Table 107. Koninklijke Philips N.V.: Key Strategic Moves and Developments
Table 108. Epic Systems Corporation: Key Executives
Table 109. Epic Systems Corporation: Company Snapshot
Table 110. Epic Systems Corporation: Operating Segments
Table 111. Epic Systems Corporation: Product Portfolio
Table 112. Epic Systems Corporation: Key Strategic Moves and Developments
Table 113. Optum, Inc.: Key Executives
Table 114. Optum, Inc.: Company Snapshot
Table 115. Optum, Inc.: Operating Segments
Table 116. Optum, Inc.: Product Portfolio
Table 117. Optum, Inc.: Key Strategic Moves and Developments
Table 118. Pointclickcare: Key Executives
Table 119. Pointclickcare: Company Snapshot
Table 120. Pointclickcare: Operating Segments
Table 121. Pointclickcare: Product Portfolio
Table 122. Pointclickcare: Key Strategic Moves and Developments
Table 123. Cerner Corporation: Key Executives
Table 124. Cerner Corporation: Company Snapshot
Table 125. Cerner Corporation: Operating Segments
Table 126. Cerner Corporation: Product Portfolio
Table 127. Cerner Corporation: Key Strategic Moves and Developments
Table 128. Philips Healthcare: Key Executives
Table 129. Philips Healthcare: Company Snapshot
Table 130. Philips Healthcare: Operating Segments
Table 131. Philips Healthcare: Product Portfolio
Table 132. Philips Healthcare: Key Strategic Moves and Developments
Table 133. Athenahealth: Key Executives
Table 134. Athenahealth: Company Snapshot
Table 135. Athenahealth: Operating Segments
Table 136. Athenahealth: Product Portfolio
Table 137. Athenahealth: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Clinical Pathway Information System Market, 2024 - 2033
Figure 2. Segmentation of Clinical Pathway Information System Market, 2024 - 2033
Figure 3. Top Investment Pocket in Clinical Pathway Information System Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalclinical Pathway Information System Market
Figure 10. Global Clinical Pathway Information System Market Segmentation, by Type
Figure 11. Clinical Pathway Information System Market for Group Order Type, by Country, 2024 - 2033 ($Billion)
Figure 12. Clinical Pathway Information System Market for Embodied Variant Type, by Country, 2024 - 2033 ($Billion)
Figure 13. Clinical Pathway Information System Market for Reconstructed Information Type, by Country, 2024 - 2033 ($Billion)
Figure 14. Global Clinical Pathway Information System Market Segmentation, by Mode of Delivery
Figure 15. Clinical Pathway Information System Market for On-Premises, by Country, 2024 - 2033 ($Billion)
Figure 16. Clinical Pathway Information System Market for Cloud-based, by Country, 2024 - 2033 ($Billion)
Figure 17. Clinical Pathway Information System Market for Web-based, by Country, 2024 - 2033 ($Billion)
Figure 18. Global Clinical Pathway Information System Market Segmentation, by End-user
Figure 19. Clinical Pathway Information System Market for Hospitals, by Country, 2024 - 2033 ($Billion)
Figure 20. Clinical Pathway Information System Market for Ambulatory Care Centers, by Country, 2024 - 2033 ($Billion)
Figure 21. Clinical Pathway Information System Market for Specialty Clinics, by Country, 2024 - 2033 ($Billion)
Figure 22. Clinical Pathway Information System Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 23. Top Winning Strategies, by Year, 2021-2023*
Figure 24. Top Winning Strategies, by Development, 2021-2023*
Figure 25. Top Winning Strategies, by Company, 2021-2023*
Figure 26. Product Mapping of Top 10 Players
Figure 27. Competitive Dashboard
Figure 28. Competitive Heatmap: Clinical Pathway Information System Market
Figure 29. Top Player Positioning, 2023
Figure 30. Mckesson Corporation: Net Sales, 2021-2023 ($Billion)
Figure 31. Mckesson Corporation: Revenue Share, by Segment, 2023 (%)
Figure 32. Mckesson Corporation: Revenue Share, by Region, 2023 (%)
Figure 33. Civica: Net Sales, 2021-2023 ($Billion)
Figure 34. Civica: Revenue Share, by Segment, 2023 (%)
Figure 35. Civica: Revenue Share, by Region, 2023 (%)
Figure 36. GE Healthcare: Net Sales, 2021-2023 ($Billion)
Figure 37. GE Healthcare: Revenue Share, by Segment, 2023 (%)
Figure 38. GE Healthcare: Revenue Share, by Region, 2023 (%)
Figure 39. Koninklijke Philips N.V.: Net Sales, 2021-2023 ($Billion)
Figure 40. Koninklijke Philips N.V.: Revenue Share, by Segment, 2023 (%)
Figure 41. Koninklijke Philips N.V.: Revenue Share, by Region, 2023 (%)
Figure 42. Epic Systems Corporation: Net Sales, 2021-2023 ($Billion)
Figure 43. Epic Systems Corporation: Revenue Share, by Segment, 2023 (%)
Figure 44. Epic Systems Corporation: Revenue Share, by Region, 2023 (%)
Figure 45. Optum, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 46. Optum, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 47. Optum, Inc.: Revenue Share, by Region, 2023 (%)
Figure 48. Pointclickcare: Net Sales, 2021-2023 ($Billion)
Figure 49. Pointclickcare: Revenue Share, by Segment, 2023 (%)
Figure 50. Pointclickcare: Revenue Share, by Region, 2023 (%)
Figure 51. Cerner Corporation: Net Sales, 2021-2023 ($Billion)
Figure 52. Cerner Corporation: Revenue Share, by Segment, 2023 (%)
Figure 53. Cerner Corporation: Revenue Share, by Region, 2023 (%)
Figure 54. Philips Healthcare: Net Sales, 2021-2023 ($Billion)
Figure 55. Philips Healthcare: Revenue Share, by Segment, 2023 (%)
Figure 56. Philips Healthcare: Revenue Share, by Region, 2023 (%)
Figure 57. Athenahealth: Net Sales, 2021-2023 ($Billion)
Figure 58. Athenahealth: Revenue Share, by Segment, 2023 (%)
Figure 59. Athenahealth: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Clinical Pathway Information System Market include:
  • McKesson Corporation
  • Civica
  • GE Healthcare
  • Koninklijke Philips N.V.
  • EPIC Systems Corporation
  • Optum, Inc.
  • PointClickCare
  • Cerner Corporation
  • Philips Healthcare
  • Athenahealth

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information